ORTHO EVRA – Talking to Your Doctor

ORTHO EVRA – Talking to Your Doctor

Mornings hectic? Lay out your work clothes the night before.

Important
Labeling Information

No time for the gym? Skip the elevator and take the stairs.

site map contact us newsroom legal notice privacy policy

Looking to save a few bucks? Don't go to the grocery store hungry; avoid those impulse buys.

Feeling rushed in the morning? Start your day 15 minutes earlier.

close

Tell-A-Friend

Share this page with a friend.

If you think someone you know might benefit from the content of the previous page, enter his or her information below. We'll send an e-mail inviting your friend to view this content, courtesy of you. By submitting an e-mail address, you are requesting that we contact on your behalf the person you specify here. Your contact information and your friend's contact information are required, but they will not be used other than to distribute the communication request. Please review our Privacy Policy.

Your Name *
Your Email *
Friend's Name *
Friend's Email *

Talking to Your Doctor

Talking to Your Doctor

Now that you’re up to speed on the benefits and possible risks of ORTHO EVRA^®, you might be thinking that the Patch is the right choice for you. This is a good time to talk to your doctor, and have a discussion about any further concerns or questions you may have. Our Patient-Doctor Discussion Guide can help to get this conversation rolling.

We’ve listed a few questions to help you get started. Simply check the box to add a question to your list. You can also customize your discussion guide by entering your own questions or add questions from the Questions About the Patch section of this site by simply clicking on the icon.

Have your list e-mailed to you, or print it directly from the site.

Patient-Doctor Discusssion Guide

Check the items that you would like to discuss, and take the list to your next appointment.

Are there other birth control methods with the same effectiveness as the Pill?

Can I explore a birth control option that doesn't require daily use?

Is there a birth control option that doen't require daily use?

Add your own questions.

I verify that I intend to send this information to myself and will not send this information to any e-mail address that is not my own.

Questions About the Patch

Email Question

Preview your questions

Are there other birth control methods with the same effectiveness as the Pill?

Can I explore a birth control option that doesn't require daily use?

Is there a birth control option that doen't require daily use?

Static Image

Always losing your keys at home? Pick one designated spot for them.

Can't sleep? Flip your mattress for a comfy new bed.

Chewing gum stuck in the carpet? Rub it with an ice cube until hard, then just pull it off.

Breath not as fresh as you'd like? Remember to brush your tongue, too.

Grocery list always missing something? Keep a running
list on your fridge door.

Overflowing closet? If you haven't worn it in a year,
toss it.

Love garlic but hate what it does to your breath?
Skip the mints; eat
parsley after your
garlicky meal

ORTHO EVRA^® is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception.
This product is available by prescription only.

Important Safety Information

Serious as well as minor side effects have been reported with the use of the Patch. Serious risks, which can be life threatening, include blood clots, stroke and heart attacks and are increased if you smoke cigarettes. Cigarette smoking increases the risk of serious cardiovascular side effects, especially if you are over 35. Women who use the Patch are strongly advised not to smoke. Some women should not use the Patch, including women who have blood clots, certain cancers, a history of heart attack, blood clots, or stroke, as well as those who are or may be pregnant.

Hormones from ORTHO EVRA^® get into the bloodstream and are processed by the body differently than hormones from birth control pills. You will be exposed to about 60% more estrogen if you use ORTHO EVRA^® than if you use a typical birth control pill containing 35 micrograms of estrogen. In general, increased estrogen may increase the risk of side effects. The risk of venous thromboembolic events (blood clots in the legs and/or the lungs) may be increased with ORTHO EVRA^® use compared with use of birth control pills. Studies examined the risk of these serious blood clots in women who used either ORTHO EVRA^® or birth control pills containing one of two progestins (levonorgestrel or norgestimate) and 30–35 micrograms of estrogen. Results of these studies ranged from an approximate doubling of risk of serious blood clots to no increase in risk in women using ORTHO EVRA^® compared to women using birth control pills.

You should discuss with your healthcare professional whether ORTHO EVRA^® is a good method of contraception for you.
The Patch does not protect against HIV or sexually transmitted diseases.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see the Detailed Patient Labeling from the full Product Information.

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2010. All rights reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy. This site is published by Ortho Women's Health & Urology^™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which is solely responsible for its contents.

Capitalized product names are registered trademarks of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

This information is intended for use by our customers, patients and healthcare professionals in the United States only. Ortho Women's Health & Urology^™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.
Last Modified On January 20, 2010